🔎 Trials Near Me

Beranda › Gagal Jantung › California › San Francisco

Uji klinis Gagal Jantung di San Francisco, CA

29 studi untuk Gagal Jantung mencari peserta di lokasi sekitar San Francisco (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

ELEVATE-HFpEF Clinical Study

Menerima peserta
  • Sutter Health Hospital, San Francisco
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Menerima pesertaFase 3
  • Research Site, San Francisco
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06307652

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Menerima pesertaFase 2
  • University of California, San Francisco, San Francisco
  • University of California San Francisco UCSF, San Francisco
Usia 40 hingga 84 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06979362

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Menerima pesertaFase 3
  • California Pacific Medical Center Van Ness Campus, San Francisco
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06736574

Alleviant ALLAY-HFrEF Study

Menerima peserta
  • University of California San Francisco, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Menerima pesertaFase 3
  • Kaiser Permanente, San Francisco
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Menerima pesertaFase 3
  • Research Site, San Francisco
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Menerima pesertaFase 3
  • San Francisco, CA Investigative Site CON-10315, San Francisco
  • CON-10023, San Francisco, CA, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Menerima pesertaFase 3
  • San Francisco, CA Investigative Site 10023, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06008197

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

Menerima peserta
  • University of California, San Francisco, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT03586336

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Menerima pesertaFase 2
  • University of California, San Francisco - Heart and Vascular Center, San Francisco
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT06793371

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Menerima peserta
  • Zuckerberg San Francisco General, San Francisco
  • University of California San Francisco, San Francisco
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05677100

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Menerima pesertaStudi observasional
  • University Of California San Francisco Medical Center, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Menerima pesertaFase 3
  • Tenax Investigational Site, San Francisco
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Menerima pesertaFase 3
  • Kaiser Permanente Northern California, San Francisco
  • San Francisco V.A. Medical Center, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001

Alleviant ALLAY-HF Study

Menerima peserta
  • University of California San Francisco, San Francisco
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT05685303

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Menerima pesertaFase 3
  • UC San Francisco Medical Center, San Francisco
Usia 2 hingga 11 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06597006

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

Menerima pesertaFase 3
  • San Francisco, CA Investigative Site FIN-10023, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Menerima peserta
  • UCSF Medical Center, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Menerima peserta
  • University of California at San Francisco, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06526195

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Menerima pesertaFase 3
  • UC San Francisco Medical Center, San Francisco
  • UC San Francisco Medical Center, San Francisco
Usia 6 hingga 11 · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT06597019

Developing a Digital Aid to Improve ICD Decisions

Menerima peserta
  • University of California, San Francisco, San Francisco
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT07084142

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Menerima peserta
  • University of California- San Francisco, San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT03142152

Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure

Menerima pesertaStudi observasional
  • University of California, San Francisco (UCSF), San Francisco
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Mar 2026 · NCT07443670

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

Menerima pesertaStudi observasional
  • UCSF, San Francisco
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 16 Des 2025 · NCT06039176

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Menerima pesertaStudi observasional
  • University of California, San Francisco, San Francisco
  • Kaiser Permanente San Francisco, San Francisco
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 26 Mar 2025 · NCT06378632

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Menerima pesertaFase 1
  • University of California San Francisco, San Francisco
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 6 Feb 2025 · NCT06228924

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Menerima pesertaFase 1/2
  • University of California, San Francisco, San Francisco
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 26 Mar 2024 · NCT04703842

Uji klinis Gagal Jantung di kota lain

Studi lain di San Francisco

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.